Please login to the form below
mongersen
This page shows the latest mongersen news and features for those working in and with pharma, biotech and healthcare.
Daily Brief: Gottlieb sets out cell and gene pathway, NICE says no to Chiesi ultra-rare treatment and more
The company’s psoriasis drug Otezla is also underperforming, and another blockbuster candidate mongersen failed in phase III.
Latest news
-
Celgene pays $300m upfront for immunology start-up Delinia
other pipeline candidates in this therapeutic category including mongersen for inflammatory bowel disease and ozanimod for multiple sclerosis which are both in late-stage testing.
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Medical Writer – Creative Healthcare Advertising – New Yo...
-
Highly Competitive Salary, Bonus &Benefits
- Scientific Director, MRNA/ Covid 19, Medical Communications, UK
-
Six figure salary
- Account Supervisor – Leading Healthcare Advertising Agency – New...
-
Highly Competitive Salary, Bonus &Benefits
- Vaccines writer – career opportunity to move into medcomms from ...
-
Highly competitive salary
- Principal Medical Writer, MRNA/ Covid 19, Medical Communications...
-
Highly competitive salary
- Client Services Director, MRNA/ Covid 19, Medical Communications...
-
Highly competitive salary
- Results for Merck’s oral cholesterol inhibitor show it to be ‘highly effective’
- US government to pay $5.3bn for Pfizer‘s Paxlovid
- Gilead to pay $745m for three oncology programmes from Arcus Biosciences
- Novo Nordisk to buy Dicerna Pharmaceuticals for $3.3bn
- AstraZeneca/Moderna’s mRNA treatment for heart failure looks promising
- US demand for COVID-19 antibody treatments rising fast
- From Academics to Entrepreneurship: How Tech is Revolutionizing the Diagnostics Landscape
- Impetus Digital wins Canada’s Most Admired Corporate Cultures Awards 2021
- Roche to present new data for its drug Polivy at the American Society of Hematology’s annual meeting
- Regeneron signs $900m cancer and infectious disease deal with Nykode
- Webinar:
- Gilead’s Trodelvy approved for triple-negative breast cancer in Europe
- Results for Merck’s oral cholesterol inhibitor show it to be ‘highly effective’
- Live Webinar: From Academics to Entrepreneurship: How Tech is Revolutionizing the Diagnostics Landscape
- Pfizer lifts 2021 guidance as sales of its BioNTech-partnered vaccine continue to climb
- Live Webinar: Gamifying Surgical Training to Improve Patient Outcomes
- AZ, Amgen’s tezepelumab reduces asthma exacerbations in broad patient population
- NICE recommends long-acting HIV therapy developed by ViiV Healthcare and Janssen
Latest intelligence
- Webinar:
- Securing a future for telehealth with immersive market research insights...
- Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
- How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
- Six ways to improve diversity in clinical trials
- Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...
